Opinion
Video
Challenges in Managing Co-Morbid CRM Conditions
Key Takeaways
- Polypharmacy and drug-drug interactions complicate the management of co-morbid CRM conditions, necessitating careful medication review and adjustment.
- Overlapping symptoms of CRM conditions require a multidisciplinary approach for accurate diagnosis and effective management.
A panel of medical experts examines the challenges in managing co-morbid cardiometabolic conditions, emphasizing the most prevalent complications associated with this disease state.
Video content above is prompted by the following:
- What are the major clinical challenges in managing patients with co-morbid CRM conditions?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Related Content
December 19th 2024
